302 related articles for article (PubMed ID: 8911985)
1. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
[TBL] [Abstract][Full Text] [Related]
2. Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.
Müller G; Satoh Y; Geisen K
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S115-37. PubMed ID: 8529504
[TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of esterification and lipolysis by palmitate, H2O2 and the anti-diabetic sulfonylurea drug, glimepiride, in rat adipocytes.
Müller G; Wied S; Straub J; Jung C
Eur J Pharmacol; 2008 Nov; 597(1-3):6-18. PubMed ID: 18789917
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipid raft proteins by glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C in rat adipocytes.
Müller G; Schulz A; Wied S; Frick W
Biochem Pharmacol; 2005 Mar; 69(5):761-80. PubMed ID: 15710354
[TBL] [Abstract][Full Text] [Related]
5. Translocation of glycosylphosphatidylinositol-anchored proteins from plasma membrane microdomains to lipid droplets in rat adipocytes is induced by palmitate, H2O2, and the sulfonylurea drug glimepiride.
Müller G; Wied S; Walz N; Jung C
Mol Pharmacol; 2008 May; 73(5):1513-29. PubMed ID: 18272749
[TBL] [Abstract][Full Text] [Related]
6. Insulin-mimetic signaling by the sulfonylurea glimepiride and phosphoinositolglycans involves distinct mechanisms for redistribution of lipid raft components.
Müller G; Jung C; Wied S; Welte S; Frick W
Biochemistry; 2001 Dec; 40(48):14603-20. PubMed ID: 11724574
[TBL] [Abstract][Full Text] [Related]
7. The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro.
Müller G; Wied S
Diabetes; 1993 Dec; 42(12):1852-67. PubMed ID: 8243832
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the actin network in insulin signalling.
Tsakiridis T; Wang Q; Taha C; Grinstein S; Downey G; Klip A
Soc Gen Physiol Ser; 1997; 52():257-71. PubMed ID: 9210235
[TBL] [Abstract][Full Text] [Related]
9. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.
Müller G; Korndörfer A; Kornak U; Malaisse WJ
Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action.
Frick W; Bauer A; Bauer J; Wied S; Müller G
Biochemistry; 1998 Sep; 37(38):13421-36. PubMed ID: 9748349
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of glimepiride on protein expression of cardiac glucose transporters.
Eckel J
Horm Metab Res; 1996 Sep; 28(9):508-11. PubMed ID: 8911988
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
[TBL] [Abstract][Full Text] [Related]
13. Association of (c)AMP-degrading glycosylphosphatidylinositol-anchored proteins with lipid droplets is induced by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes.
Müller G; Over S; Wied S; Frick W
Biochemistry; 2008 Feb; 47(5):1274-87. PubMed ID: 18186652
[TBL] [Abstract][Full Text] [Related]
14. MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes.
Harmon AW; Paul DS; Patel YM
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E758-66. PubMed ID: 15172888
[TBL] [Abstract][Full Text] [Related]
15. Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans.
Müller G; Wied S; Piossek C; Bauer A; Bauer J; Frick W
Mol Med; 1998 May; 4(5):299-323. PubMed ID: 9642681
[TBL] [Abstract][Full Text] [Related]
16. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
Enrique-Tarancón G; Castan I; Morin N; Marti L; Abella A; Camps M; Casamitjana R; Palacín M; Testar X; Degerman E; Carpéné C; Zorzano A
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
[TBL] [Abstract][Full Text] [Related]
17. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipolysis by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets.
Müller G; Wied S; Over S; Frick W
Biochemistry; 2008 Feb; 47(5):1259-73. PubMed ID: 18186616
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of conventional sulfonylureas and glimepiride.
Geisen K; Végh A; Krause E; Papp JG
Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade.
Müller G; Wied S; Wetekam EM; Crecelius A; Unkelbach A; Pünter J
Biochem Pharmacol; 1994 Aug; 48(5):985-96. PubMed ID: 8093111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
